Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FU.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FU.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.4.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.4.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GY.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.14.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.14.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.14.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.7.14.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.14.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.3.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.3.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DY.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DY.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DY.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.48NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.48NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.48NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.49NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.49NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.49NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.14.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.7.14.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.14.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.4.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.4.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used